Alzamend Neuro
ALZN
10 hedge funds and large institutions have $387K invested in Alzamend Neuro in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
16% more capital invested
Capital invested by funds: $335K → $387K (+$52K)
0% more ownership
Funds ownership: 0.06% → 0.06% (+0%)
29% less funds holding
Funds holding: 14 → 10 (-4)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$25.2K |
| 2 |
Renaissance Technologies
New York
|
+$3.43K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$15K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.7K |
| 3 |
Morgan Stanley
New York
|
-$86 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$42 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Truist Financial
Charlotte,
North Carolina
| $154K | – | – | – |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $78.5K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $52.4K | – | – | – |
|
4
BlackRock
New York
| $39.7K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $26K | +$25.2K | +294 | New |
|
|
RA
6
RFG Advisory
Birmingham,
Alabama
| $16.7K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $14K | +$3.43K | +40 | +35% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $4.75K | +$1.37K | +16 | +43% |
|
|
HIA
9
Harbor Investment Advisory
Lutherville,
Maryland
| $200 | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $66 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $39 | – | – | – |
|
|
12
Morgan Stanley
New York
| $33 | -$86 | -1 | Closed |
|
|
PA
13
Parallel Advisors
San Francisco,
California
| $33 | – | – | – |
|
|
HF
14
HRT Financial
New York
| – | -$15K | -187 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$1.7K | -21 | Closed |
|
|
16
Bank of America
Charlotte,
North Carolina
| – | -$42 | -1 | Closed |
|
ALZN Hedge Fund Activity: Q1 2024 in Review
10 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q1 2024, worth a combined $387K — up 16% from $335K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ALZN and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $25.2K. The largest seller was HRT Financial, exiting entirely with an estimated $15K sold.
- 10 institutional investors held Alzamend Neuro (ALZN) as of Q1 2024, down from 14 in Q4 2023.
- Funds reported $387K of Alzamend Neuro stock for Q1 2024, up 16% quarter-over-quarter.
- 1 fund opened new Alzamend Neuro positions in Q1 2024 and 4 closed out, a net change of -3 holders.
- The largest Alzamend Neuro buyer in Q1 2024 was Virtu Financial, an estimated $25.2K added.
- The largest Alzamend Neuro seller in Q1 2024 was HRT Financial, an estimated $15K sold.
Based on aggregated 13F filings for Q1 2024.